iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.88% | 8.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.64% | 5.63% | |||
| Operating Income | -6.54% | -10.41% | |||
| Income Before Tax | -6.21% | -11.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.21% | -11.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.21% | -11.39% | |||
| EBIT | -6.54% | -10.41% | |||
| EBITDA | -6.43% | -11.13% | |||
| EPS Basic | 27.21% | -3.14% | |||
| Normalized Basic EPS | 27.23% | -3.15% | |||
| EPS Diluted | 27.21% | -3.14% | |||
| Normalized Diluted EPS | 27.23% | -3.15% | |||
| Average Basic Shares Outstanding | 45.91% | 7.99% | |||
| Average Diluted Shares Outstanding | 45.91% | 7.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||